Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. - ROE

The ROE as of September 2026 (TTM) for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) is -5.84%

According to Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.’s latest financial reports and current stock price. The company's current ROE is -5.84%. This represents a change of 294.03% compared to the average of -1.48% of the last 4 quarters.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) Historical ROE (quarterly & annually)

How has 1349.HK ROE performed in the past?

The mean historical ROE of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. over the last ten years is 8.38%. The current -5.84% ROE has changed -169.65% with respect to the historical average. Over the past ten years (40 quarters), 1349.HK's ROE was at its highest in in the December 2019 quarter at 11.37%. The ROE was at its lowest in in the December 2025 quarter at -6.69%.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) ROE by Quarter and Year

Discovering the peaks and valleys of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) Average ROE

How has 1349.HK ROE performed in the past?

The current ROE of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) ROE vs. Peers

How is 1349.HK’s ROE compared to its peers?

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.’s ROE is less than Lee's Pharmaceutical Holdings Limited (7.52%), less than Jilin Province Huinan Changlong Bio-pharmacy Company Limited (15.91%), greater than Sunho Biologics, Inc. (-39.21%), greater than Venus Medtech (Hangzhou) Inc. (-28.24%), less than Arrail Group Limited (1.27%), less than Tian An Medicare Limited (0.48%), less than EuroEyes International Eye Clinic Limited (0.20%), greater than Transcenta Holding Limited (-32.08%), less than Sirnaomics Ltd. (133.13%), less than Pak Fah Yeow International Limited (13.59%),

Build a custom stock screener for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.